Similar heparin-free aggregation studies have been performed for the recombinant form of a tau peptide (amino acid 297–391) that is a major component of PHF tau isolated from Alzheimer’s disease brains (Al-Hilaly et al., 2017, 2018, 2019). The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.